Raymond James & Associates Cronos Group Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Cronos Group Inc. stock. As of the latest transaction made, Raymond James & Associates holds 28,633 shares of CRON stock, worth $57,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,633
Previous 28,643 0.03%
Holding current value
$57,552
Previous $66,000 6.06%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$2.08 - $2.49 $20 - $24
-10 Reduced 0.03%
28,633 $62,000
Q2 2024

Jul 19, 2024
SELL
$2.27 - $3.02 $2,270 - $3,020
-1,000 Reduced 3.37%
28,643 $66,000
Q1 2024

Apr 22, 2024
SELL
$1.93 - $2.7 $9,711 - $13,586
-5,032 Reduced 14.51%
29,643 $77,000
Q4 2023

Jan 16, 2024
SELL
$1.72 - $2.19 $7,924 - $10,089
-4,607 Reduced 11.73%
34,675 $72,000
Q3 2023

Oct 24, 2023
SELL
$1.68 - $2.47 $5,426 - $7,978
-3,230 Reduced 7.6%
39,282 $78,000
Q2 2023

Jul 25, 2023
BUY
$1.67 - $2.04 $440 - $538
264 Added 0.62%
42,512 $83,000
Q1 2023

Apr 14, 2023
SELL
$1.87 - $2.6 $19,232 - $26,741
-10,285 Reduced 19.58%
42,248 $81,000
Q4 2022

Feb 08, 2023
BUY
$2.49 - $3.5 $28,311 - $39,795
11,370 Added 27.62%
52,533 $133,000
Q3 2022

Oct 25, 2022
SELL
$2.82 - $3.58 $41,651 - $52,876
-14,770 Reduced 26.41%
41,163 $116,000
Q2 2022

Aug 12, 2022
SELL
$2.59 - $3.92 $84,358 - $127,678
-32,571 Reduced 36.8%
55,933 $158,000
Q1 2022

May 11, 2022
BUY
$3.0 - $4.25 $68,565 - $97,133
22,855 Added 34.81%
88,504 $344,000
Q4 2021

Feb 08, 2022
SELL
$3.85 - $6.71 $48,914 - $85,250
-12,705 Reduced 16.21%
65,649 $257,000
Q3 2021

Nov 02, 2021
SELL
$5.6 - $8.58 $118,322 - $181,286
-21,129 Reduced 21.24%
78,354 $443,000
Q2 2021

Aug 11, 2021
BUY
$7.16 - $9.41 $166,570 - $218,914
23,264 Added 30.52%
99,483 $856,000
Q1 2021

May 14, 2021
BUY
$7.52 - $15.55 $91,037 - $188,248
12,106 Added 18.88%
76,219 $721,000
Q4 2020

Feb 12, 2021
BUY
$5.0 - $8.85 $113,360 - $200,647
22,672 Added 54.71%
64,113 $445,000
Q3 2020

Nov 04, 2020
BUY
$4.96 - $7.08 $28,157 - $40,193
5,677 Added 15.87%
41,441 $208,000
Q2 2020

Jul 28, 2020
SELL
$4.84 - $8.02 $5,754 - $9,535
-1,189 Reduced 3.22%
35,764 $215,000
Q1 2020

Apr 21, 2020
SELL
$4.52 - $8.55 $16,000 - $30,267
-3,540 Reduced 8.74%
36,953 $210,000
Q4 2019

Feb 12, 2020
BUY
$6.14 - $9.3 $32,063 - $48,564
5,222 Added 14.81%
40,493 $311,000
Q3 2019

Nov 07, 2019
BUY
$9.05 - $16.02 $139,795 - $247,460
15,447 Added 77.92%
35,271 $319,000
Q2 2019

Aug 06, 2019
BUY
$13.58 - $18.61 $121,350 - $166,298
8,936 Added 82.07%
19,824 $317,000
Q1 2019

May 06, 2019
BUY
$11.31 - $23.7 $123,143 - $258,045
10,888 New
10,888 $201,000

Others Institutions Holding CRON

# of Institutions
210
Shares Held
47.5M
Call Options Held
3.38M
Put Options Held
1.6M
View Full List

About Cronos Group Inc.

CRON Quotes by TradingView
  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email